Omega-3 fatty acid improves the clinical outcome of hepatectomized patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma

por Wu, Zhengshan, Qin, Jianjie, Pu, Liyong
Publicado 2012

Aging deteriorated liver Ischemia and reperfusion injury by suppressing Tribble’s proteins 1 mediated macrophage polarization

por Chen, Qi, Song, Yating, Yang, Ningli, Ai, Xiaoming, Pu, Liyong, Kong, Lianbao
Publicado 2023

Boronic Acid-Modified Magnetic Fe(3)O(4)@mTiO(2) Microspheres for Highly Sensitive and Selective Enrichment of N-Glycopeptides in Amniotic Fluid

por Shi, Zhonghua, Pu, Liyong, Guo, Yueshuai, Fu, Ziyi, Zhao, Wene, Zhu, Yunxia, Wu, Jindao, Wang, Fuqiang
Publicado 2017

circLARP4 induces cellular senescence through regulating miR‐761/RUNX3/p53/p21 signaling in hepatocellular carcinoma

por Chen, Zhiqiang, Zuo, Xueliang, Pu, Liyong, Zhang, Yao, Han, Guoyong, Zhang, Long, Wu, Jindao, Wang, Xuehao
Publicado 2019

Inhibiting ATP6V0D2 Aggravates Liver Ischemia-Reperfusion Injury by Promoting NLRP3 Activation via Impairing Autophagic Flux Independent of Notch1/Hes1

por Wang, Ziyi, Wang, Hao, Chen, Xuejiao, Han, Sheng, Zhu, Yulin, Wang, Hanhua, Cheng, Feng, Pu, Liyong
Publicado 2021

Myeloid Trem2 Dynamically Regulates the Induction and Resolution of Hepatic Ischemia-Reperfusion Injury Inflammation

por Han, Sheng, Li, Xiangdong, Xia, Nan, Zhang, Yu, Yu, Wenjie, Li, Jie, Jiao, Chenyu, Wang, Ziyi, Pu, Liyong
Publicado 2023

Correction: miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6

por Jiang, Weiwei, Kong, Liangliang, Ni, Qingfeng, Lu, Yeting, Ding, Wenzhou, Liu, Guoqing, Pu, Liyong, Tang, Weibing, Kong, Lianbao
Publicado 2023

miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6

por Jiang, Weiwei, Kong, Liangliang, Ni, Qingfeng, Lu, Yeting, Ding, Wenzhou, Liu, Guoqing, Pu, Liyong, Tang, Weibing, Kong, Lianbao
Publicado 2014

Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma

por Chen, Zhiqiang, Pu, Liyong, Gao, Wen, Zhang, Long, Han, Guoyong, Zhu, Qin, Li, Xiangcheng, Wu, Jindao, Wang, Xuehao
Publicado 2017

Impact of insurance status on the survival of gallbladder cancer patients

por Chen, Zhiqiang, Gao, Wen, Pu, Liyong, Zhang, Long, Han, Guoyong, Zhu, Qin, Li, Xiangcheng, Wu, Jindao, Wang, Xuehao
Publicado 2017

HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation

por Li, Qing, Ni, Yong, Zhang, Liren, Jiang, Runqiu, Xu, Jing, Yang, Hong, Hu, Yuanchang, Qiu, Jiannan, Pu, Liyong, Tang, Jinhai, Wang, Xuehao
Publicado 2021

Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment

por Chen, Xuejiao, Wang, Ziyi, Han, Sheng, Wang, Zeng, Zhang, Yu, Li, Xiangdong, Xia, Nan, Yu, Wenjie, Jia, Chenyang, Ni, Yong, Pu, Liyong
Publicado 2021

Blockade of Hepatocyte PCSK9 Ameliorates Hepatic Ischemia-Reperfusion Injury by Promoting Pink1-Parkin–Mediated Mitophagy

por Zhang, Yu, Wang, Ziyi, Jia, Chenyang, Yu, Wenjie, Li, Xiangdong, Xia, Nan, Nie, Huiling, Wikana, Likalamu Pascalia, Chen, Minhao, Ni, Yong, Han, Sheng, Pu, Liyong
Publicado 2023

Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma

por Shen, Jian, Wang, Weizhi, Wu, Jindao, Feng, Bing, Chen, Wen, Wang, Meng, Tang, Jincao, Wang, Fuqiang, Cheng, Feng, Pu, Liyong, Tang, Qiyun, Wang, Xuehao, Li, Xiangcheng
Publicado 2012

Hypomethylation‐mediated activation of cancer/testis antigen KK‐LC‐1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling

por Chen, Zhiqiang, Zuo, Xueliang, Pu, Liyong, Zhang, Yao, Han, Guoyong, Zhang, Long, Wu, Zhengshan, You, Wei, Qin, Jianjie, Dai, Xinzheng, Shen, Hongbing, Wang, Xuehao, Wu, Jindao
Publicado 2019

Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6/STAT3

por Li, Xiangdong, Wang, Ziyi, Jiao, Chenyu, Zhang, Yu, Xia, Nan, Yu, Wenjie, Chen, Xuejiao, Wikana, Likalamu Pascalia, Liu, Yue, Sun, Linfeng, Chen, Minhao, Xiao, Yuhao, Shi, Yuhua, Han, Sheng, Pu, Liyong
Publicado 2023

PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells

por Li, Qing, Zhang, Liren, You, Wenhua, Xu, Jiali, Dai, Jingjing, Hua, Dongxu, Zhang, Ruizhi, Yao, Feifan, Zhou, Suiqing, Huang, Wei, Dai, Yongjiu, Zhang, Yu, Baheti, Tasiken, Qian, Xiaofeng, Pu, Liyong, Xu, Jing, Xia, Yongxiang, Zhang, Chuanyong, Tang, Jinhai, Wang, Xuehao
Publicado 2022

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

por Xia, Yongxiang, Tang, Weiwei, Qian, Xiaofeng, Li, Xiangcheng, Cheng, Feng, Wang, Ke, Zhang, Feng, Zhang, Chuanyong, Li, Donghua, Song, Jinhua, Zhang, Hui, Zhao, Jie, Yao, Aihua, Wu, Xiaofeng, Wu, Chen, Ji, Guwei, Liu, Xisheng, Zhu, Feipeng, Qin, Lang, Xiao, Xuan, Deng, Zhenhua, Kong, Xiangyi, Li, Si, Yu, Yangyang, Xi, Wenjing, Deng, Wanglong, Qi, Chuang, Liu, Hanyuan, Pu, Liyong, Wang, Ping, Wang, Xuehao
Publicado 2022